Carta científico-clínica
Leishmaniasis cutánea en un paciente con artritis psoriásica tratado con infliximab: tratamiento con crioterapia y Glucantime® intralesional
Cutaneous leishmaniasis in a patient receiving infliximab for psoriatic arthritis: treatment with cryotherapy and intralesional meglumine antimonate
Leído
7949
Vecesse ha leído el artículo
2602
Total PDF
5347
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 65 | 20 | 85 |
| 2025 5 | 99 | 28 | 127 |
| 2025 4 | 97 | 27 | 124 |
| 2025 3 | 106 | 22 | 128 |
| 2025 2 | 123 | 36 | 159 |
| 2025 1 | 94 | 30 | 124 |
| 2024 12 | 68 | 31 | 99 |
| 2024 11 | 74 | 55 | 129 |
| 2024 10 | 75 | 54 | 129 |
| 2024 9 | 65 | 27 | 92 |
| 2024 8 | 69 | 76 | 145 |
| 2024 7 | 71 | 34 | 105 |
| 2024 6 | 85 | 30 | 115 |
| 2024 5 | 71 | 23 | 94 |
| 2024 4 | 80 | 19 | 99 |
| 2024 3 | 65 | 29 | 94 |
| 2024 2 | 65 | 25 | 90 |
| 2024 1 | 41 | 32 | 73 |
| 2023 12 | 59 | 16 | 75 |
| 2023 11 | 53 | 23 | 76 |
| 2023 10 | 39 | 20 | 59 |
| 2023 9 | 50 | 26 | 76 |
| 2023 8 | 40 | 20 | 60 |
| 2023 7 | 99 | 39 | 138 |
| 2023 6 | 48 | 22 | 70 |
| 2023 5 | 87 | 43 | 130 |
| 2023 4 | 49 | 21 | 70 |
| 2023 3 | 61 | 24 | 85 |
| 2023 2 | 66 | 17 | 83 |
| 2022 1 | 63 | 30 | 93 |
| 2022 12 | 61 | 27 | 88 |
| 2022 11 | 75 | 43 | 118 |
| 2022 10 | 100 | 49 | 149 |
| 2022 9 | 66 | 48 | 114 |
| 2022 8 | 70 | 46 | 116 |
| 2022 7 | 66 | 46 | 112 |
| 2022 6 | 52 | 34 | 86 |
| 2022 5 | 67 | 36 | 103 |
| 2022 4 | 62 | 49 | 111 |
| 2022 3 | 63 | 43 | 106 |
| 2022 2 | 46 | 23 | 69 |
| 2021 1 | 95 | 31 | 126 |
| 2021 12 | 58 | 36 | 94 |
| 2021 11 | 59 | 45 | 104 |
| 2021 10 | 55 | 42 | 97 |
| 2021 9 | 74 | 42 | 116 |
| 2021 8 | 64 | 25 | 89 |
| 2021 7 | 62 | 25 | 87 |
| 2021 6 | 46 | 25 | 71 |
| 2021 5 | 50 | 30 | 80 |
| 2021 4 | 72 | 65 | 137 |
| 2021 3 | 51 | 21 | 72 |
| 2021 2 | 56 | 24 | 80 |
| 2020 1 | 41 | 22 | 63 |
| 2020 12 | 45 | 20 | 65 |
| 2020 11 | 42 | 19 | 61 |
| 2020 10 | 35 | 12 | 47 |
| 2020 9 | 51 | 10 | 61 |
| 2020 8 | 30 | 15 | 45 |
| 2020 7 | 22 | 18 | 40 |
| 2020 6 | 37 | 13 | 50 |
| 2020 5 | 18 | 16 | 34 |
| 2020 4 | 34 | 18 | 52 |
| 2020 3 | 28 | 14 | 42 |
| 2020 2 | 9 | 2 | 11 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 8 | 5 | 13 |
| 2019 11 | 4 | 5 | 9 |
| 2019 10 | 4 | 5 | 9 |
| 2019 9 | 0 | 5 | 5 |
| 2019 8 | 4 | 4 | 8 |
| 2019 7 | 11 | 2 | 13 |
| 2019 6 | 5 | 15 | 20 |
| 2019 5 | 10 | 14 | 24 |
| 2019 4 | 3 | 26 | 29 |
| 2019 3 | 21 | 10 | 31 |
| 2019 2 | 4 | 9 | 13 |
| 2019 1 | 5 | 5 | 10 |
| 2018 12 | 0 | 5 | 5 |
| 2018 11 | 1 | 5 | 6 |
| 2018 10 | 2 | 10 | 12 |
| 2018 9 | 5 | 4 | 9 |
| 2018 8 | 2 | 13 | 15 |
| 2018 7 | 2 | 10 | 12 |
| 2018 6 | 0 | 18 | 18 |
| 2018 5 | 0 | 19 | 19 |
| 2018 4 | 2 | 16 | 18 |
| 2018 3 | 11 | 8 | 19 |
| 2018 2 | 106 | 9 | 115 |
| 2018 1 | 68 | 12 | 80 |
| 2017 12 | 98 | 6 | 104 |
| 2017 11 | 45 | 20 | 65 |
| 2017 10 | 38 | 8 | 46 |
| 2017 9 | 36 | 13 | 49 |
| 2017 8 | 34 | 18 | 52 |
| 2017 7 | 21 | 10 | 31 |
| 2017 6 | 39 | 17 | 56 |
| 2017 5 | 32 | 21 | 53 |
| 2017 4 | 25 | 15 | 40 |
| 2017 3 | 29 | 28 | 57 |
| 2017 2 | 20 | 24 | 44 |
| 2016 1 | 24 | 8 | 32 |
| 2016 12 | 36 | 14 | 50 |
| 2016 11 | 41 | 24 | 65 |
| 2016 10 | 60 | 49 | 109 |
| 2016 9 | 64 | 23 | 87 |
| 2016 8 | 4 | 13 | 17 |
| 2016 7 | 5 | 1 | 6 |
| 2016 6 | 9 | 1 | 10 |
| 2016 5 | 6 | 4 | 10 |
| 2016 4 | 5 | 3 | 8 |
| 2016 3 | 5 | 5 | 10 |
| 2016 2 | 7 | 3 | 10 |
| 2015 1 | 12 | 3 | 15 |
| 2015 12 | 11 | 0 | 11 |
| 2015 11 | 20 | 1 | 21 |
| 2015 10 | 13 | 1 | 14 |
| 2015 9 | 10 | 3 | 13 |
| 2015 8 | 11 | 2 | 13 |
| 2015 7 | 38 | 8 | 46 |
| 2015 6 | 42 | 6 | 48 |
| 2015 5 | 39 | 16 | 55 |
| 2015 4 | 26 | 2 | 28 |
| 2015 3 | 28 | 7 | 35 |
| 2015 2 | 19 | 8 | 27 |
| 2015 1 | 12 | 12 | 24 |
| 2014 12 | 22 | 4 | 26 |
| 2014 11 | 20 | 6 | 26 |
| 2014 10 | 34 | 8 | 42 |
| 2014 9 | 36 | 20 | 56 |
Mostrar todo
